dr. hwang on the evolution of treatment in metastatic cspc
Published 4 years ago • 59 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:22
dr. hwang on the state of treatment in metastatic prostate cancer
-
1:16
dr. hwang on the utility of antiandrogens in metastatic prostate cancer
-
2:22
dr. hwang on treatment selection in metastatic castration-sensitive prostate cancer
-
6:16
evolution of treatment for metastatic castration-resistant prostate cancer
-
2:09
dr. hwang on choosing agents for prostate cancer treatment
-
1:06
dr. hwang on the utility of docetaxel in mcspc
-
1:06
dr. hamid on the progression of therapy for metastatic prostate cancer
-
1:28:53
hormones and cancer: separating fact from fiction with dr. peter fotinos
-
1:20
dr. hwang on the addition of radium-223 to abiraterone acetate and prednisone in mcrpc
-
9:22
conclusion: final thoughts on treating metastatic prostate cancer
-
0:53
dr. freedland on real-world utility of enzalutamide in prostate cancer
-
10:55
the impact of local treatment in patients with newly diagnosed metastatic prostate cancer
-
1:11
dr. burgess on the synergy between abiraterone and adt in prostate cancer
-
1:07
dr. penson on treatment selection in metastatic hormone-sensitive prostate cancer
-
1:14
dr. dreicer on abiraterone and enzalutamide in prostate cancer
-
1:27
dr. zhang discusses the impact of the stampede trial in prostate cancer
-
1:29
dr. choi on evolution of rt in prostate cancer
-
1:34
dr. chi on the titan trial results in metastatic castration-sensitive prostate cancer
-
9:23
hormone-sensitive metastatic prostate cancer